Pubblicazioni

Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report

2022 - ANTI-CANCER DRUGS

Stellato, M.; Foderaro, S.; Tonini, G.; Vincenzi, B.; Santini, D.

ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more

2021 - INTERNATIONAL IMMUNOPHARMACOLOGY

Stellato, M.; Santini, D.

Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators

2021 - JOURNAL OF TRANSLATIONAL MEDICINE

Stellato, M.; Procopio, G.; De Giorgi, U.; Maruzzo, M.; Bimbatti, D.; Mennitto, A.; Sbrana, A.; Roviello, G.; Casadei, C.; Sepe, P.; Pignata, S.; Santini, D.

Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)

2021 - AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS

Santini, D; Stellato, M; De Giorgi, U; Pantano, F; De Lisi, D; Casadei, C; Maruzzo, M; Bimbatti, D; Naglieri, E; Buti, S; Bersanelli, M; De Vivo, R; Di Lorenzo, G; Sbrana, A; Verzoni, E; Soraru', M; Fornarini, G; Mucciarini, C; Grillone, F; Mini, E; Vignani, F; Attademo, L; Pignata, S; Procopio, G

Metastatic Renal Cell Carcinoma Classified as Good Risk: The Easiest Choice Has Become the Hardest

2021 - CHEMOTHERAPY

Stellato, M.; Santini, D.

Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old. Analysis of the REnal SURGery in Elderly (RESURGE) Group

2020 - EUROPEAN UROLOGY FOCUS

Bindayi, A.; Autorino, R.; Capitanio, U.; Pavan, N.; Mir, M. C.; Antonelli, A.; Takagi, T.; Bertolo, R.; Maurer, T.; Ho Rha, K.; Long, J. A.; Yang, B.; Schips, L.; Lima, E.; Breda, A.; Linares, E.; Celia, A.; De Nunzio, C.; Dobbs, R.; Patel, S.; Hamilton, Z.; Tracey, A.; Larcher, A.; Trombetta, C.; Palumbo, C.; Tanabe, K.; Amiel, T.; Raheem, A.; Fiard, G.; Zhang, C.; Castellucci, R.; Palou, J.; Ryan, S.; Crivellaro, S.; Montorsi, F.; Porpiglia, F.; Derweesh, I. H.

Response to cabozantinib in renal cell carcinoma with cardiac metastases

2020 - ANTI-CANCER DRUGS

Stellato, M; Cursano, Mc; Citarella, F; Pantano, F; Russano, M; Dell'Aquila, E; Vincenzi, B; Tonini, G; Santini, D.

Radiation therapy in renal cell carcinoma

2018 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, Francesca; Tombolini, Vincenzo

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

2018 - FUTURE ONCOLOGY

Bracarda, S.; Galli, L.; Maruzzo, M.; Lo Re, G.; Buti, Sebastiano; Favaretto, A.; Di Costanzo, F.; Sacco, C.; Merlano, M.; Mucciarini, C.; Zafarana, E.; Romito, S.; Maestri, A.; Giorgio, C. G.; Ionta, M. T.; Turci, D.; De Giorgi, U.; Procopio, G.; Cortesi, E.; Giannarelli, D.; Porta, C.

Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells

2015 - CANCER BIOLOGY & THERAPY

Grimaldi, A; Santini, D; Zappavigna, S; Lombardi, A; Misso, G; Boccellino, M; Desiderio, V; Vitiello, Pp; Di Lorenzo, G; Zoccoli, A; Pantano, F; Caraglia, M.